Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

Yu Yu, Stephanie Gaillard, JudeM Phillip, Tai Chung Huang, SnehaM Pinto, NayaraG Tessarollo, Zhen Zhang, Akhilesh Pandey, Denis Wirtz, Ayse Ayhan, Ben Davidson, Tian-Li Wang, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response.

Original languageEnglish (US)
Pages (from-to)82-96
Number of pages15
JournalCancer Cell
Volume28
Issue number1
DOIs
StatePublished - Jul 13 2015

Fingerprint

Paclitaxel
Microtubules
Ovarian Neoplasms
Gene Knockdown Techniques
Syk Kinase
Phosphotyrosine
Microtubule-Associated Proteins
Carboplatin
Proteome
Tubulin
Drug Resistance
Neoplasms
Carcinoma
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology
  • Medicine(all)

Cite this

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules. / Yu, Yu; Gaillard, Stephanie; Phillip, JudeM; Huang, Tai Chung; Pinto, SnehaM; Tessarollo, NayaraG; Zhang, Zhen; Pandey, Akhilesh; Wirtz, Denis; Ayhan, Ayse; Davidson, Ben; Wang, Tian-Li; Shih, Ie Ming.

In: Cancer Cell, Vol. 28, No. 1, 13.07.2015, p. 82-96.

Research output: Contribution to journalArticle

Yu, Yu ; Gaillard, Stephanie ; Phillip, JudeM ; Huang, Tai Chung ; Pinto, SnehaM ; Tessarollo, NayaraG ; Zhang, Zhen ; Pandey, Akhilesh ; Wirtz, Denis ; Ayhan, Ayse ; Davidson, Ben ; Wang, Tian-Li ; Shih, Ie Ming. / Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules. In: Cancer Cell. 2015 ; Vol. 28, No. 1. pp. 82-96.
@article{12d4b11f69d4416cb16afc542ce93b28,
title = "Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules",
abstract = "Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response.",
author = "Yu Yu and Stephanie Gaillard and JudeM Phillip and Huang, {Tai Chung} and SnehaM Pinto and NayaraG Tessarollo and Zhen Zhang and Akhilesh Pandey and Denis Wirtz and Ayse Ayhan and Ben Davidson and Tian-Li Wang and Shih, {Ie Ming}",
year = "2015",
month = "7",
day = "13",
doi = "10.1016/j.ccell.2015.05.009",
language = "English (US)",
volume = "28",
pages = "82--96",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

AU - Yu, Yu

AU - Gaillard, Stephanie

AU - Phillip, JudeM

AU - Huang, Tai Chung

AU - Pinto, SnehaM

AU - Tessarollo, NayaraG

AU - Zhang, Zhen

AU - Pandey, Akhilesh

AU - Wirtz, Denis

AU - Ayhan, Ayse

AU - Davidson, Ben

AU - Wang, Tian-Li

AU - Shih, Ie Ming

PY - 2015/7/13

Y1 - 2015/7/13

N2 - Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response.

AB - Resistance to chemotherapy represents a major obstacle for long-term remission, and effective strategies toovercome drug resistance would have significant clinical impact. We report that recurrent ovarian carcinomas after paclitaxel/carboplatin treatment have higher levels of spleen tyrosine kinase (SYK) and phospho-SYK. Invitro, paclitaxel-resistant cells expressed higher SYK, and the ratio of phospho-SYK/SYK positively associated with paclitaxel resistance in ovarian cancer cells. Inactivation of SYK by inhibitors or gene knockdown sensitized paclitaxel cytotoxicity invitro and invivo. Analysis of the phosphotyrosine proteome in paclitaxel-resistant tumor cells revealed that SYK phosphorylates tubulins and microtubule-associated proteins. Inhibition of SYK enhanced microtubule stability in paclitaxel-resistant tumor cells that were otherwise insensitive. Thus, targeting SYK pathway is a promising strategy to enhance paclitaxel response.

UR - http://www.scopus.com/inward/record.url?scp=84937441218&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937441218&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.05.009

DO - 10.1016/j.ccell.2015.05.009

M3 - Article

C2 - 26096845

AN - SCOPUS:84937441218

VL - 28

SP - 82

EP - 96

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 1

ER -